These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8380830)
1. Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit. Raynaud F; Gerbaud P; Bouloc A; Gorin I; Anderson WB; Evain-Brion D J Invest Dermatol; 1993 Jan; 100(1):77-81. PubMed ID: 8380830 [TBL] [Abstract][Full Text] [Related]
2. A cAMP binding abnormality in psoriasis. Raynaud F; Gerbaud P; Enjolras O; Gorin I; Donnadieu M; Anderson WB; Evain-Brion D Lancet; 1989 May; 1(8648):1153-6. PubMed ID: 2566733 [TBL] [Abstract][Full Text] [Related]
3. Retinoylation of the type II cAMP-binding regulatory subunit of cAMP-dependent protein kinase is increased in psoriatic human fibroblasts. Tournier S; Raynaud F; Gerbaud P; Lohmann SM; Anderson WB; Evain-Brion D J Cell Physiol; 1996 May; 167(2):196-203. PubMed ID: 8613459 [TBL] [Abstract][Full Text] [Related]
4. Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts. Liapi C; Takahashi N; Raynaud F; Evain-Brion D; Anderson WB J Invest Dermatol; 1998 Apr; 110(4):332-7. PubMed ID: 9540970 [TBL] [Abstract][Full Text] [Related]
5. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Raynaud F; Evain-Brion D; Gerbaud P; Marciano D; Gorin I; Liapi C; Anderson WB Free Radic Biol Med; 1997; 22(4):623-32. PubMed ID: 9013125 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of cyclic AMP-dependent protein kinases in human psoriasis. Brion DE; Raynaud F; Plet A; Laurent P; Leduc B; Anderson W Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5272-6. PubMed ID: 3014540 [TBL] [Abstract][Full Text] [Related]
7. A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. Schopf RE; Langendorf Y; Benz RE; Färber L; Benes P J Invest Dermatol; 2002 Jul; 119(1):160-5. PubMed ID: 12164939 [TBL] [Abstract][Full Text] [Related]
8. Acitretin : A Review of its Pharmacology and Therapeutic Use. Pilkington T; Brogden RN Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560 [TBL] [Abstract][Full Text] [Related]
9. Post-translational abnormality of the type II cyclic AMP-dependent protein kinase in psoriasis: modulation by retinoic acid. Tournier S; Gerbaud P; Anderson WB; Lohmann SM; Evain-Brion D; Raynaud F J Cell Biochem; 1995 Apr; 57(4):647-54. PubMed ID: 7615649 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate. Downs SM; Hunzicker-Dunn M Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815 [TBL] [Abstract][Full Text] [Related]
11. Changes in the activity and subcellular distribution of cyclic-AMP-dependent protein kinases with retinoic-acid-induced differentiation of embryonal carcinoma cells. Plet A; Gerbaud P; Anderson WB; Brion DE Differentiation; 1985; 30(2):159-64. PubMed ID: 3007248 [TBL] [Abstract][Full Text] [Related]
12. cAMP-binding proteins in medullary tubules from rat kidney: effect of ADH. Gapstur SM; Homma S; Dousa TP Am J Physiol; 1988 Aug; 255(2 Pt 2):F292-300. PubMed ID: 2841870 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a cyclic AMP-resistant Chinese hamster ovary cell mutant containing both wild-type and mutant species of type I regulatory subunit of cyclic AMP-dependent protein kinase. Singh TJ; Hochman J; Verna R; Chapman M; Abraham I; Pastan IH; Gottesman MM J Biol Chem; 1985 Nov; 260(26):13927-33. PubMed ID: 2997187 [TBL] [Abstract][Full Text] [Related]
14. Retinoid treatment of human psoriatic fibroblasts induces an increase in cyclic AMP-dependent protein kinase activity. Raynaud F; Leduc C; Anderson WB; Evain-Brion D J Invest Dermatol; 1987 Jul; 89(1):105-10. PubMed ID: 3598199 [TBL] [Abstract][Full Text] [Related]
15. Deletion of cAMP-binding site B in the regulatory subunit of cAMP-dependent protein kinase alters the photoaffinity labeling of site A. Ringheim GE; Saraswat LD; Bubis J; Taylor SS J Biol Chem; 1988 Dec; 263(34):18247-52. PubMed ID: 2848031 [TBL] [Abstract][Full Text] [Related]
16. Nucleolar accumulation of cyclic adenosine 3':5'-monophosphate receptor proteins during regression of MCF-7 human breast tumor. Kapoor CL; Grantham F; Cho-Chung YS Cancer Res; 1984 Aug; 44(8):3554-60. PubMed ID: 6331652 [TBL] [Abstract][Full Text] [Related]
17. Adenosine 3',5'-monophosphate-binding capacity in small and large ovine luteal cells. Hoyer PB; Niswender GD Endocrinology; 1986 Oct; 119(4):1822-9. PubMed ID: 3019646 [TBL] [Abstract][Full Text] [Related]
18. Compartmentation of the type I regulatory subunit of cAMP-dependent protein kinase in cardiac ventricular muscle. Reinitz CA; Bianco RA; Shabb JB Arch Biochem Biophys; 1997 Dec; 348(2):391-402. PubMed ID: 9434753 [TBL] [Abstract][Full Text] [Related]
19. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors. Butley MS; Stoner GD; Beer DG; Beer DS; Mason RJ; Malkinson AM Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675 [TBL] [Abstract][Full Text] [Related]
20. DNA-mediated gene transfer of a mutant regulatory subunit of cAMP-dependent protein kinase. Abraham I; Brill S; Hyde J; Fleischmann R; Chapman M; Gottesman MM J Biol Chem; 1985 Nov; 260(26):13934-40. PubMed ID: 2997188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]